Overview

Intralesional Steroid Injection Versus Voice Therapy in Management of Vocal Nodules

Status:
Recruiting
Trial end date:
2022-02-01
Target enrollment:
0
Participant gender:
Female
Summary
Vocal nodules represent 16 % of benign vocal fold lesions.They are caused by chronic voice abuse or misuse and often occur in children and adult females. The resultant dysphonia leads to personal, social and occupational problems. The first line of treatment is voice rest and voice therapy. The Accent method is a holistic technique for behavior readjustment voice therapy which targets various voice parameters as loudness, pitch and timbre. However, voice rest and voice therapy are sometimes difficult to be carried out in patients with voice-related occupations. So, complete resolution may not be possible in all patients. When voice therapy is inefficient, resection is performed by laryngeal microsurgery under general anesthesia. However, the role of surgery is much restricted.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Assiut University
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:

- 1- Female patients diagnosed with bilateral vocal fold soft edematous nodules with
preserved stroboscopic waves , don't exceed base 2.5 mm and apex .5mm.

2- age: 18-55 years. 3- Normal articulation, resonance and language ability. 4- Normal
hearing.

Exclusion Criteria:

- 1- Previous voice therapy or micro-phono-surgery. 2- Use of drugs (which may cause
changes in laryngeal function, mucosa, or muscle activity).

3- History of allergies, lung disease, gastroesophageal reflux disease, or other
concomitant vocal pathology (e.g., vocal polyp and vocal cyst).

4- Current psychiatric, neurological conditions.